Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E — Kathrin S. Michelsen (2004) | RDL Network
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
Proceedings of the National Academy of Sciences 101(29): 10679-10684
Article 2004 English
Authors
KM
Kathrin S. Michelsen
MW
Michelle Wong
PS
Prediman K. Shah
Abstract
1 min read
Toll-like receptors (TLRs) and the downstream adaptor molecule myeloid differentiation factor 88 (MyD88) play an essential role in the innate immune responses. Here, we demonstrate that genetic deficiency of TLR4 or MyD88 is associated with a significant reduction of aortic plaque areas in atherosclerosis-prone apolipoprotein E-deficient mice, despite persistent hypercholesterolemia, implying an important role for the innate immune system in atherogenesis. Apolipoprotein E-deficient mice that also lacked TLR4 or MyD88 demonstrated reduced aortic atherosclerosis that was associated with reductions in circulating levels of proinflammatory cytokines IL-12 or monocyte chemoattractant protein 1, plaque lipid content, numbers of macrophage, and cyclooxygenase 2 immunoreactivity in their plaques. Endothelial-leukocyte adhesion in response to minimally modified low-density lipoprotein was reduced in aortic endothelial cells derived from MyD88-deficient mice. Taken together, our results suggest an important role for TLR4 and MyD88 signaling in atherosclerosis in a hypercholesterolemic mouse model, providing a pathophysiologic link between innate immunity, inflammation, and atherogenesis.
Christine Koulis, Yung‐Chih Chen, Christian Hausding, Ingo Ahrens, Tin Kyaw, Christopher Tay, Terri J. Allen, Karin Jandeleit‐Dahm, Matthew J. Sweet, Akira Shizuo, A. Bobik, Karlheinz Peter, Alex Agrotis
Discussion(0)
No comments yet. Be the first to comment.